Related Experiment Videos
Alopecia and mood stabilizers: two case reports
C Uehlinger1, L Barrelet, M Touabi
1Hôpital Psychiatrique Cantona, Perreux/Neuchätel, Switzerland.
European Archives of Psychiatry and Clinical Neuroscience
|January 1, 1992
Summary
Lithium and valproate can cause toxic alopecia, a diffuse hair loss condition. Hair typically regrows completely after discontinuing these mood stabilizer medications.
Area of Science:
- Pharmacology
- Dermatology
- Neurology
Background:
- Mood stabilizers like lithium and valproate are essential for managing bipolar disorder and other psychiatric conditions.
- Adverse drug reactions, including hair loss, can impact patient adherence and quality of life.
Observation:
- This study presents two cases of toxic alopecia in patients undergoing treatment with lithium and valproate.
- The observed hair loss was diffuse, though not typically total, consistent with previous reports.
Findings:
- Hair regrowth was observed in both cases after medication adjustment or discontinuation.
- In one case, switching from lithium to valproate led to hair regrowth; in the other, stopping valproate resulted in recovery.
Implications:
- Alopecia associated with mood stabilizers necessitates careful patient evaluation and management.
- Understanding these adverse effects is crucial for optimizing treatment strategies and patient care in psychiatric pharmacotherapy.